An Intelligent Virtual-Reality System with Multi-Model Sensing for Cue-Elicited Craving in Patients with Methamphetamine Use Disorder

2021 ◽  
pp. 1-1
Author(s):  
Meng-Chang Tsai ◽  
Chia-Ru Chung ◽  
Chun-Chuan Chen ◽  
Shih-Ching Yeh ◽  
Jyun-Yu Chen ◽  
...  
Keyword(s):  
Virtual Reality ◽  
Virtual Reality System ◽  
Methamphetamine Use ◽  
Methamphetamine Use Disorder

Development of a Lower Limb Tracking Flexion/Extension Virtual Reality System

2015 ◽  
Vol 9 (6) ◽  
pp. 600
Author(s):  
Sergio Valdivia-Trujillo ◽  
Eliana Prada-Dominguez ◽  
Estefania Ramos-Montilla ◽  
Alvaro Joffre Uribe-Quevedo
Keyword(s):  
Virtual Reality ◽  
Lower Limb ◽  
Virtual Reality System ◽  
Flexion Extension

scholarly journals 639 Co-occuring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah

2021 ◽  
Vol 224 (2) ◽  
pp. S401-S402
Author(s):  
Marcela Smid ◽  
Amanda A. Allshouse ◽  
Kristine Campbell ◽  
Michelle P. Debbink ◽  
Adam G. Gordon ◽  
...  
Keyword(s):  
Maternal Morbidity ◽  
Morbidity And Mortality ◽  
Severe Maternal Morbidity ◽  
Methamphetamine Use ◽  
Maternal Morbidity And Mortality ◽  
Methamphetamine Use Disorder

Virtual Reality System for Industrial Motor Maintenance Training

2020 ◽  
Author(s):  
Taina Ribeiro de Oliveira ◽  
Tiago Fonseca Martinelli ◽  
Bianca Pina Bello ◽  
Juliana Davel Batista ◽  
Matheus Moura da Silva ◽  
...  
Keyword(s):  
Virtual Reality ◽  
Virtual Reality System

scholarly journals Hole Concealment Algorithm Using Camera Parameters in Stereo 360 Virtual Reality System

2021 ◽  
Vol 11 (5) ◽  
pp. 2033
Author(s):  
Sangguk Cha ◽  
Da-Yoon Nam ◽  
Jong-Ki Han
Keyword(s):  
Virtual Reality ◽  
Virtual Reality System ◽  
Camera Parameters

Virtual reality (VR) has been one of the most important topics in the field of multimedia signals and systems for approximately 10 years [...]

scholarly journals Parkin regulates drug-taking behavior in rat model of methamphetamine use disorder

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Akhil Sharma ◽  
Arman Harutyunyan ◽  
Bernard L. Schneider ◽  
Anna Moszczynska
Keyword(s):  
Neural Substrates ◽  
Genetically Engineered ◽  
Wild Type ◽  
Therapeutic Approaches ◽  
Self Administration ◽  
Methamphetamine Use ◽  
New Therapeutic Approaches ◽  
Extended Access ◽  
High Doses ◽  
Methamphetamine Use Disorder

AbstractThere is no FDA-approved medication for methamphetamine (METH) use disorder. New therapeutic approaches are needed, especially for people who use METH heavily and are at high risk for overdose. This study used genetically engineered rats to evaluate PARKIN as a potential target for METH use disorder. PARKIN knockout, PARKIN-overexpressing, and wild-type young adult male Long Evans rats were trained to self-administer high doses of METH using an extended-access METH self-administration paradigm. Reinforcing/rewarding properties of METH were assessed by quantifying drug-taking behavior and time spent in a METH-paired environment. PARKIN knockout rats self-administered more METH and spent more time in the METH-paired environment than wild-type rats. Wild-type rats overexpressing PARKIN self-administered less METH and spent less time in the METH-paired environment. PARKIN knockout rats overexpressing PARKIN self-administered less METH during the first half of drug self-administration days than PARKIN-deficient rats. The results indicate that rats with PARKIN excess or PARKIN deficit are useful models for studying neural substrates underlying “resilience” or vulnerability to METH use disorder and identify PARKIN as a novel potential drug target to treat heavy use of METH.

Sign in / Sign up

Export Citation Format

Share Document